BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 23429337)

  • 1. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild cognitive impairment].
    Papp E; Pákáski M; Drótos G; Kálmán J
    Psychiatr Hung; 2012; 27(6):426-34. PubMed ID: 23429337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is it pseudo-dementia? The validation of the Adas-Cog questionnaire in Hungary].
    Drótos G; Pákáski M; Papp E; Kálmán J
    Psychiatr Hung; 2012; 27(2):82-91. PubMed ID: 22700619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early Mental Test--developing a screening test for mild cognitive impairment].
    Kálmán J; Pákáski M; Hoffmann I; Drótos G; Darvas G; Boda K; Bencsik T; Gyimesi A; Gulyás Z; Bálint M; Szatlóczki G; Papp E
    Ideggyogy Sz; 2013 Jan; 66(1-2):43-52. PubMed ID: 23607229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of the Hungarian Test Your Memory (TYM-HUN), MMSE, and ADAS-Cog tests for patients with mild cognitive impairment (MCI) in a Hungarian population: a cross-sectional study.
    Garbóczy S; Magócs É; Szőllősi GJ; Harsányi S; Égerházi A; Kolozsvári LR
    BMC Psychiatry; 2020 Dec; 20(1):571. PubMed ID: 33256672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
    Zainal NH; Silva E; Lim LL; Kandiah N
    Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the utility of everyday memory test and the Alzheimer's Disease Assessment Scale-Cognitive part for evaluation of mild cognitive impairment and very mild Alzheimer's disease.
    Adachi H; Shinagawa S; Komori K; Toyota Y; Mori T; Matsumoto T; Sonobe N; Kashibayashi T; Ishikawa T; Fukuhara R; Ikeda M
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):148-53. PubMed ID: 23581865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale--cognitive subscale].
    Pákáski M; Drótos G; Janka Z; Kálmán J
    Orv Hetil; 2012 Mar; 153(12):461-6. PubMed ID: 22411219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
    Ben Jemaa S; Attia Romdhane N; Bahri-Mrabet A; Jendli A; Le Gall D; Bellaj T
    J Alzheimers Dis; 2017; 60(1):11-21. PubMed ID: 28505978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value and functional correlations of the ADAS-Cog scale in Alzheimer's disease: data on NORMACODEM project].
    Monllau A; Pena-Casanova J; Blesa R; Aguilar M; Bohm P; Sol JM; Hernandez G
    Neurologia; 2007 Oct; 22(8):493-501. PubMed ID: 17602338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of Slovenian version of ADAS-Cog for patients with mild cognitive impairment and Alzheimer's disease.
    Ulbl J; Rakusa M
    Acta Neurol Belg; 2022 Jun; 122(3):695-702. PubMed ID: 34424494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hungarian version of the Montreal Cognitive Assessment (MoCA) for screening mild cognitive impairment].
    Volosin M; Janacsek K; Németh D
    Psychiatr Hung; 2013; 28(4):370-92. PubMed ID: 24443573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian estimation for the accuracy of three neuropsychological tests in detecting Alzheimer's disease and mild cognitive impairment: a retrospective analysis of the ADNI database.
    Wang X; Li F; Tian J; Gao Q; Zhu H
    Eur J Med Res; 2023 Oct; 28(1):427. PubMed ID: 37821912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI.
    Skinner J; Carvalho JO; Potter GG; Thames A; Zelinski E; Crane PK; Gibbons LE;
    Brain Imaging Behav; 2012 Dec; 6(4):489-501. PubMed ID: 22614326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DemTect®--effective to asses MCI and dementia--validation study of the Polish language version.
    Wojtyńska R; Szcześniak D
    Aging Ment Health; 2016; 20(5):510-6. PubMed ID: 25811731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.